“The answer is yes, and those who wish to obtain a consultation with an experienced Actos bladder cancer lawyer for an evaluation of what compensation and legal options may be available to them should use the following link,” said Resource4thePeople.
In the Los Angeles trial, Bloomberg News reported that Howard Greenberg, a clinical pharmacologist, testified that Takeda officials, in 2005 e-mails, were concerned about whether U.S. and European drug regulators might force the company to issue warning labels about a bladder cancer risk and whether that might affect sales.**
“There are multiple e-mails from different levels of Takeda management that indicate the product came first,” Greenberg told jurors in the first day of testimony about Jack Cooper’s claims over Actos.
Cooper is suing Takeda over claims that he developed bladder cancer as a result of his use of Actos for more than four years, according to the court file in the case.
He is a retired telephone company worker who, according to the court file, was diagnosed with bladder cancer in 2011. His lawyer told jurors in opening statements that Cooper had been in “good shape” before he started on the medication, regularly walking five miles, repairing his own roof and going deep-sea fishing with his grandchildren, according to Bloomberg News.
The Los Angeles trial is one component of the Actos bladder cancer litigation. As this case proceeds other federal court cases that have been consolidated into a federal multi-district litigation are still pending.***
Multi-district litigations are designated by a special federal panel that chooses a single judge to oversee pre-trial evidence-gathering and other legal activities before deciding whether to grant such cases class-action status.
That judge, U.S. District Judge Rebecca Doherty, has scheduled the first bellwether trial i
Copyright©2012 Vocus, Inc.
All rights reserved